Fondazione Ca Granda IRCCS

Milano, Italy

Fondazione Ca Granda IRCCS

Milano, Italy
SEARCH FILTERS
Time filter
Source Type

Randi M.L.,University of Padua | Bertozzi I.,University of Padua | Rumi E.,University of Pavia | Elena C.,University of Pavia | And 13 more authors.
American Journal of Hematology | Year: 2014

Although Philadelphia-negative myeloproliferative neoplasms (MPNs) occur typically in middle to advanced age, any age group may be affected, posing a challenge for their management during pregnancy when they occur in young females. There is a high incidence of thromboembolic events and pregnancy complications in patients with myeloproliferative neoplasms, and a possible relationship between these complications is a matter of concern. The aim of this article was to correlate thrombosis and pregnancy outcome in 158 females with ET experiencing 237 pregnancies. Seven patients had a thrombotic event before their first pregnancy, one of them ended (14.3%) in a miscarriage. Among the 151 patients with no history of thrombosis before they became pregnant, 40 (26.5%) had a miscarriage (P=NS). Eighteen patients (11.4%) developed major thrombotic complications (12 splanchnic vein, 1 cerebral vein, 2 coronary syndromes, and 3 strokes) after at least one pregnancy (4 uneventful and 14 complicated). The occurrence of thrombosis was significantly more frequent (P<0.001) in patients with a history of pregnancy complications (28%) than in those experiencing a normal pregnancy and delivery (3.7%). Pregnancy complications in women with ET are associated with a higher risk of subsequent thromboses, so pregnant women with this neoplasm who miscarry need to be carefully monitored. © 2013 Wiley Periodicals, Inc.

Loading Fondazione Ca Granda IRCCS collaborators
Loading Fondazione Ca Granda IRCCS collaborators